RSV prophylaxis: Palivizumab, nirsevimab, and more
Current prevention strategies include 2 injectables for infants and young children, namely palivizumab and nirsevimab.
What's going on with polio, monkeypox, and COVID-19
The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?
Full recap from the 2025 Pediatric Academic Societies meeting
In this article, we recap our top stories, expert interviews, and Q+A discussions from the 2025 Pediatric Academic Societies meeting.
What Omicron could mean for the pandemic
Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.
Antibiotic use before age 2 linked to higher childhood BMI
Early antibiotic use before age 2 is linked to higher childhood obesity risk, with timing playing a key role in long-term weight outcomes.
ACIP votes in favor of recently FDA approved vaccines for meningococcal disease, chikungunya
Recommendations from the ACIP are forwarded to the director of the CDC, and if adopted, become official CDC policy.
